The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

along with his background in Oncology drug development, Christoph will be a valuable addition to our leadership team.” "I am energized to bring my experience to Byondis and to join such an ...

FairJourney Biologics S.A., global leader in antibody discovery and development, today announced the formation of its Supervisory Board to support the Company's ongoing strategy for growth and ...

Synthetic biology specialist GRO Biosciences started exploring strategic alternatives about six months after raising a series ...

along with his background in Oncology drug development, Christoph will be a valuable addition to our leadership team." "I am energized to bring my experience to Byondis and to join such an ...

Merck, and Vodafone, where he led large-scale marketing initiatives that shaped traditional, digital, and social engagement strategies. “Frank’s impressive background in marketing, sales ...

Merck, and Vodafone, where he led large-scale marketing initiatives that shaped traditional, digital, and social engagement strategies. “Frank’s impressive background in marketing, sales, and the ...

All lines have been placed on mute to prevent any background noise ... collaboration agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as ...

This year, as we seek to strengthen, refine and ensure the relevance of the index, Spear’s has again collaborated closely with the expert team at Thuso Group ... it has taken place against the a ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...